The newly issued CPT code goes into effect on July 1, 2025. San Francisco-based Eko said it marks the first step to coverage and reimbursement for Sensora, an AI-powered heart disease detection platform.
Eko utilizes its Sensora platform, which uses AI in cardiac disease detection with its smart stethoscope technology. In addition to low EF and structural heart murmur, the platform features an FDA-cleared algorithm for identifying AFib.
Sensora seamlessly integrates with the Core 500 digital stethoscope, which embeds advanced ECG technology in a tool for providers. Using the smart stethoscope, providers can quickly detect abnormal heart rhythms during a routine physical exam.
(Medical Design & Outsourcing: How Eko Health’s AI-powered stethoscope detects early signs of heart failure.)
Eko said the Category III CPT code reflects Sensora’s growing role as an assential tool in cardiac care. The company expects it to expand the technology’s use across multiple clinical environments.
“The AMA’s creation of Category III CPT code for Eko’s AI disease detection algorithms is a major step in increasing access to early heart disease detection,” said Connor Landgraf, CEO of Eko Health. “This milestone will help enable clinicians to use powerful, validated tools to identify heart disease early, ultimately improving patient outcomes, especially in communities with limited access to specialist care.”
